Biomerieux (France) Today
| BIM Stock | EUR 98.85 0.20 0.20% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Biomerieux is trading at 98.85 as of the 29th of November 2024, a 0.2% down since the beginning of the trading day. The stock's open price was 99.05. Biomerieux has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Biomerieux SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2023 and ending today, the 29th of November 2024. Click here to learn more.
bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. The company has 118.37 M outstanding shares. More on Biomerieux SA
Moving together with Biomerieux Stock
Moving against Biomerieux Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biomerieux Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biomerieux's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomerieux or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Biomerieux SA (BIM) is traded on Euronext Paris in France and employs 12,084 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerieux's market, we take the total number of its shares issued and multiply it by Biomerieux's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biomerieux SA operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 118.37 M outstanding shares.
Biomerieux SA has accumulated about 280.1 M in cash with 811.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38.
Check Biomerieux Probability Of Bankruptcy
Ownership AllocationBiomerieux holds a total of 118.37 Million outstanding shares. Biomerieux SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.28 percent of Biomerieux SA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biomerieux Ownership Details
Biomerieux SA Risk Profiles
Although Biomerieux's alpha and beta are two of the key measurements used to evaluate Biomerieux's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9736 | |||
| Standard Deviation | 1.38 | |||
| Variance | 1.91 | |||
| Risk Adjusted Performance | (0.04) |
Biomerieux Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomerieux without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Biomerieux Corporate Management
Elected by the shareholders, the Biomerieux's board of directors comprises two types of representatives: Biomerieux inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biomerieux. The board's role is to monitor Biomerieux's management team and ensure that shareholders' interests are well served. Biomerieux's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biomerieux's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frederic Beseme | Head CSR | Profile | |
| Guillaume Bouhours | Ex CFO | Profile | |
| Pierre Boulud | Chief Operations | Profile | |
| Franois Lacoste | Ex RD | Profile | |
| Mark Miller | Ex Affairs | Profile | |
| Alexandre Merieux | Chairman CEO | Profile | |
| Valerie Leylde | Communications HR | Profile |
Other Information on Investing in Biomerieux Stock
Biomerieux financial ratios help investors to determine whether Biomerieux Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomerieux with respect to the benefits of owning Biomerieux security.